Kenya BioVax Institute Limited hosted a Workshop on Chartering the Roadmap to the First Vial, bringing together leadership, partners, and experts driving Kenya’s vaccine manufacturing agenda.
Keynote Speaker Mr. Joe Sang, EBS, Managing Director – Kenya Pipeline Company Limited, delivered insights on harnessing private-sector efficiency and offered practical approaches for boards and management to accelerate progress in strategic industries.
The session was graced by the Kenya BioVax Institute Limited Board of Directors, led by Chairman Dr. Charles Githinji, alongside the Senior Management Team. We were also honored to host Dr. Bernard Olayo from the World Bank, among other distinguished participants.
This engagement reinforces our commitment to building a resilient, efficient, globally competitive vaccine ecosystem for Kenya and the region.
